Trulieve Cannabis Corp

TRLV

時価総額 $19.3億

Marijuana stocks could soon see a big jump in overall momentum in the near future. Most of this is based on the growth and expansion of certain public companies. In 2026, we are soon to see the official start of cannabis being rescheduled to class 3. This will most likely come with an uphill battle at first. But there is a lot in the works and much to be done for future investing and trading to show sustainable patterns. Right now, the cannabis sector for marijuana stocks is still filled with a large amount of volatility. This volatility has given some investors the chance to find top marijuana stocks to buy at lower-than-normal prices.

Here, we highlight three medical product stocks, ICUI, NEOG and TRLV, which are well positioned to benefit from industry tailwinds and could be worth adding to investors' portfolios.

TALLAHASSEE, Fla., Oct. 7, 2026 /PRNewswire/ -- Trulieve Cannabis Corp. (NYSE: TRLV) ("Trulieve" or "the Company"), a leading and top-performing medical cannabis company in the U.S., today announced the full repayment of an approximately $65 million mortgage notes payable secured by a cultivation site in Jefferson County, Florida, thereby reducing outstanding debt to approximately $225 million.

TALLAHASSEE, Fla., Oct. 6, 2026 /PRNewswire/ -- Trulieve Cannabis Corp. (NYSE: TRLV ) ("Trulieve" or "the Company"), a leading and top-performing medical cannabis company in the U.S., will hold a conference call on Thursday, November 5, 2026 at 8:30 AM Eastern Time following the release of its third quarter 2026 financial results.

The two pot companies had higher second-quarter profit. Their balance sheets are stronger than other companies in the sector.

I reiterate my Buy rating on AdvisorShares Pure US Cannabis ETF despite the DEA pausing rescheduling hearings. MSOS remains attractive as the rescheduling catalyst is delayed, not canceled, and underlying holdings appear reasonably valued. Trulieve Cannabis Corp., MSOS's largest holding, stands out due to its Florida medical sales focus and normalized tax rates.

Trulieve Cannabis falls after the Drug Enforcement Administration pauses pending rescheduling proceedings for a case that could federally recognize cannabis for medical use.

The marijuana industry is entering another important period for investors as September 2026 gets underway. Cannabis stocks have experienced significant volatility over the past several years. However, several major operators continue building their businesses despite challenging industry conditions.

Perpetual Royalty-Free License Covers Alien Labs and Connected Brands TALLAHASSEE, Fla., Sept. 28, 2026 /PRNewswire/ -- Trulieve Cannabis Corp. (NYSE: TRLV) ("Trulieve" or "the Company"), a leading and top-performing medical cannabis company in the U.S, today announced a licensing deal with Connected for the exclusive rights to genetics, trademarks, and proprietary know-how to produce and sell Alien Labs and Connected branded cannabis products in Florida and Texas.

Cannabis stocks are entering a potentially transformative period as federal reform takes hold. Stronger business fundamentals and wider market access are reshaping the legal cannabis industry. For cannabis investors and enthusiasts, this moment represents more than short-term stock-market excitement—it reflects the gradual evolution of cannabis from a restricted market into a more established American industry.